v3.22.2.2
Note 1 - Description of Business (Details Textual)
3 Months Ended 9 Months Ended
Jun. 24, 2021
shares
Sep. 30, 2022
USD ($)
Jun. 30, 2022
USD ($)
Mar. 31, 2022
USD ($)
Sep. 30, 2021
USD ($)
Jun. 30, 2021
USD ($)
Mar. 31, 2021
USD ($)
Sep. 30, 2022
USD ($)
Sep. 30, 2021
USD ($)
Dec. 31, 2021
USD ($)
Number of Subsidiaries               2    
Cash and Cash Equivalents, at Carrying Value, Total   $ 506,098           $ 506,098   $ 1,844,732
Retained Earnings (Accumulated Deficit), Total   (144,075,557)           (144,075,557)   $ (129,482,141)
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total   $ (3,356,915) $ (3,490,547) $ (7,759,933) $ (12,733,250) $ (6,591,723) $ (5,286,646) $ (14,607,395) $ (24,625,038)  
ImQuest [Member]                    
Conversion of Stock, Shares Converted (in shares) | shares 12,000,000                  
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares) | shares 3,282,089                  
BioLab 612 [Member]                    
Number of Wholly Owned Subsidiaries               1    
GPI [Member]                    
Equity Method Investment, Ownership Percentage   50.00%           50.00%